ThinkGenetic procures $1.5 mln
Summary
The investors included Cian Robinson , executive director of the innovation, research and real estate investments division of Lafayette General Health System. LAFAYETTE, La., February 19, 2019 (Newswire.com) – ThinkGenetic, Inc. (www.ThinkGenetic.com), makers of an artificial intelligence-driven SymptomMatcher™ for genetic disorders, today announced the successful close of its angel round of funding for $1.5M. ThinkGenetic plans to use the funds to expand its range of services and personnel, create new partnerships and develop new cutting-edge technology to complement current offerings. In addition, the new relationship with Lafayette General Health System will bring new services to Louisiana including clinical trials and electronic medical record reviews. “We’ve had the honor of being considered and accepted to several accelerator programs,” explain ThinkGenetic CEO, Dave Jacob, “The excitement and passion in Lafayette is second to none.